DWTX · Dogwood Therapeutics Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 1.04 USD |
|---|---|
| 1-day change | -14.8% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 11 / 12 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 2 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +96.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.8% |
| Market cap (USD) | $46.8M |